United States Federal Circuit
Smithkline Beecham Corp. v. Apotex Corp. Inc., 03-1285, 03-1313
In a patent infringement dispute concerning an antidepressant drug, judgment in favor of defendant is affirmed where the disputed patent is invalid as anticipated under 35 U.S.C. section 102(b).
Appellate Information
- Decided 04/08/2005
- Published 04/08/2005
Judges
- Before RADER, BRYSON, and GAJARSA, Circuit Judges.
Court
- United States Federal Circuit
Counsel
- For Appellant:
- Ford F. Farabow, Jr., Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., of Washington, DC, argued for plaintiffs-appellants. With him on the brief were Robert D. Bajefsky, Howard W. Levine, Scott J. Popma, Jennifer S. Swan, Aaron M. Raphael.
- For Appellees:
- Deanne M. Mazzochi, Lord, Bissell & Brook, of Chicago, Illinois, argued for defendants-cross-appellants. With her on the brief were Hugh L. Moore, Keith D. Parr, Hugh S. Balsam, and Kevin M. Nelson. Of counsel were Paul J. Molino, Scott B. Feder, and William A. Rakoczy.